Journal List > J Korean Ophthalmol Soc > v.55(5) > 1009961

Jun and Chang: Clinical Features of Posterior Capsule Rupture during Phacoemulsification Performed by Novice Ophthalmologists

Abstract

Purpose

To report the related factors of posterior capsule rupture and the difference of postoperative visual prognosis after phacoemulsification by analyzing clinical features of the surgery performed by ten novice ophthalmologists.

Methods

We retrospectively evaluated electronic medical records of 326 patients (412 phacoemulsification cases) who underwent surgery by novice ophthalmologists certified by the Board of Ophthalmology after a resident training program.

Results

The number of cataract surgeries performed by each surgeon within the ophthalmology fellowship period (6 months - 2 years) ranged from 16 to 75 eyes, and perioperative posterior capsule ruptures occurred in 64 of 412 eyes (15.5%). Factors such as age, sex, laterality, axial length and clinical courses were not related to the rate of posterior capsule rupture. Nucleosclerosis was significantly related to the posterior capsule rupture rate and was especially higher in the group with a grade higher than five compared to that in the groups with a grade less than 5 based on the Lens Opacities Classification System III (p = 0.033). Factors of surgeon's subspecialty, nucleofractis method, and period between residency and the fellowship were not related to the posterior capsule rupture rate, except when considering anesthetic methods. The posterior capsule rupture rate was less frequent in the retrobulbar surgery group than the topical surgery group (p = 0.046). Postoperative visual outcomes were significantly different at postoperative day one and one month (p = 0.023, 0.022, respectively) but not at postoperative two months (p = 0.059).

Conclusions

Phacoemulsifications performed by novice ophthalmologists showed a statistically significant difference in posterior capsule rupture rate between nucleosclerosis and anesthesia groups. Postoperative visual outcome differed at postoperative day one and one month but not after two months postoperatively.

References

1. Eom Y, Kang SY, Kim HM, Song JS. A survey report on cataract surgical experiences during ophthalmology residency in korea. J Korean Ophthalmol Soc. 2011; 52:429–33.
crossref
2. Park UC, Kwon JW, Han YK. Clinical results of posterior capsule ruptures in the first 1000 phacoemulsification cases. J Korean Ophthalmol Soc. 2005; 46:1270–5.
3. Park JW, Kim MS. Analysis of cause and outcome of posterior capsular rupture during phacoemulsification in cataract surgery. J Korean Ophthalmol Soc. 2003; 44:1311–6.
4. Tabandeh H, Smeets B, Teimory M, Seward H. Learning phacoemulsification: the surgeon-in-training. Eye (Lond). 1994; 8:475–7.
crossref
5. Rutar T, Porco TC, Naseri A. Risk factors for intraoperative complications in resident-performed phacoemulsification surgery. Ophthalmol. 2009; 116:431–6.
crossref
6. Woodfield AS, Gower EW, Cassard SD, Ramanthan S. Intraoperative phacoemulsification complication rates of second- and third-year ophthalmology residents a 5-year comparison. Ophthalmology. 2011; 118:954–8.
7. Blomquist PH, Morales ME, Tong L, Ahn C. Risk factors for vitreous complications in resident-performed phacoemulsification surgery. J Cataract Refract Surg. 2012; 38:208–14.
crossref
8. Briszi A, Prahs P, Hillenkamp J, et al. Complication rate and risk factors for intraoperative complications in resident-performed pha-coemulsification surgery. Graefes Arch Clin Exp Ophthalmol. 2012; 250:1315–20.
crossref
9. Kelman CD. Symposium: Phacoemulsification. Summary of personal experience. Trans Am Acad Ophthalmol Otolaryngol. 1974; 78:OP35–8.
10. Pedersen OO. Phacoemulsification and intraocular lens implantation in patients with cataract. Experiences of a beginning phacoemulsification surgeon. Acta Ophthalmol (Copenh). 1990; 68:59–64.
11. Cruz OA, Wallace GW, Gay CA, et al. Visual results and complications of phacoemulsification with intraocular lens implantation performed by ophthalmology residents. Ophthalmol. 1992; 99:448–52.
crossref
12. Bae GJ, Kim KB, Joo CK. Clinical results of posterior capsular rupture during cataract operation. J Korean Ophthalmol Soc. 1993; 34:993–8.
13. Kim KB, Jeun EJ, Kim JC. Clinical results of the eyes with posterior capsule rupture during cataract operation. J Korean Ophthalmol Soc. 1998; 39:2647–52.
14. Muhtaseb M, Kalhoro A, Ionides A. A system for preoperative stratification of cataract patients according to risk of intraoperative complications: a prospective analysis of 1441 cases. Br J Ophthalmol. 2004; 88:1242–6.
crossref
15. Gupta A, Singh J, Dhillon B. Cataract classification system for risk stratification in surgery. J Cataract Refract Surg. 2011; 37:1363–4.
crossref
16. Abbasoglu OE, Hosal B, Tekeli O, Gursel E. Risk factors for vitreous loss in cataract surgery. Eur J Ophthalmol. 2000; 10:227–32.
17. Park GS, Shyn KH. Risk factors for posterior capsular rupture in cataract surgery. J Korean Ophthalmol Soc. 2002; 43:1418–22.
18. Ünal M, Yucel I, Sarici A, et al. Phacoemulsification with topical anesthesia: Resident experience. J Cataract Refract Surg. 2006; 32:1361–5.
crossref

Figure 1.
Comparative diagrams of anesthetic methods groups during phacoemulsification (left) and preoperative nucleosclerosis groups (right) in rate of posterior capsule rupture. The rate of posterior capsule rupture is statistically higher in topical anesthesia group than retrobulbar group (p = 0.046). The rate of posterior capsule rupture significantly increases along the nucleosclerosis group (p = 0.033). Asterisks indicate statistically significant difference between groups (p < 0.05). PCR = posterior capsule rupture.
jkos-55-679f1.tif
Figure 2.
The rate of posterior capsule rupture (PCR) dramatically decreased 5th 10 cases (asterisk). The rate slightly increased 6th 10 cases, but decreased again abruptly over 70 cases. PCR rate means summation of each surgeon's PCR number per every 10 cases of phacoemulsification.
jkos-55-679f2.tif
Figure 3.
Serial visual acuity curve of phacoemulsification in each surgeon. Visual acuity in each operator group are different at postoperative 1 day and 1 month (p = 0.023, 0.022, respectively). However, at postoperative 2 months, there is no difference in each operator group (p = 0.059). Asterisks indicate statistically significant differences of visual acuity after phacoemulsification at each time point (p < 0.05). Preop = preoperative; Postop = postoperative.
jkos-55-679f3.tif
Table 1.
Patient demographics
Factors Values
Age (years) 67.6 ± 10.8 (19-88)
Sex (%)
 Male 151 (36.7)
 Female 261 (63.3)
Laterality (%)
 Right 201 (48.8)
 Left 211 (51.2)
Clinical course (%)
 Outpatient 354 (85.9)
 Inpatient 58 (14.1)

Values are presented as mean ± SD.

Table 2.
Surgical characteristics of surgeons and posterior capsule rupture of each surgeon
Surgeon number Total number of cases (person) PCR (n) PCR (%) Nucleofractis Anesthesia G-P
1 39 (32) 4 10.3 Prechop Retrobulbar No
2 19(12) 7 36.8 Prechop Retrobulbar No
3 40 (36) 4 10 Prechop Retrobulbar No
4 16 (13) 6 37.5 Prechop Retrobulbar No
5 57 (48) 12 21.1 Chop Topical No
6 75 (58) 10 13.3 Chop Retrobulbar Yes
7 44 (34) 4 9.1 Prechop Retrobulbar Yes
8 22 (16) 3 13.6 Chop Retrobulbar Yes
9 47 (38) 3 6.4 Prechop/Chop Retrobulbar Yes
10 53 (39) 12 22.6 Prechop Topical Yes
Total 412 (326) 64 15.5

PCR = posterior capsule rupture; G-P = gap-period.

Table 3.
Candidate factors that affect the rate of posterior capsule rupture
Factors Number of PCR (rate of PCR) p-value§
Sex Male
24 (15.8%)
Female
40 (15.3%)
0.889
Age Group 1* Group 2* Group 3* Group 4* 0.174
1 (4%) 36 (19%) 23 (14.3%) 4 (10.5%)
Laterality OD
32 (16%)
OS
32 (15%)
0.788
Admission Inpatient
11 (18.6%)
Outpatient
53 (15.0%)
0.443
Subspecialty Cataract and Refractive
35 (14.5%)
Others
29 (16.9%)
0.582
Axial length Group 1 Group 2 Group 3 0.517
16 (19.8%) 25 (14.4%) 21 (15.7%)
Anesthesia Retrobulbar
40 (13.2%)
Topical
24 (21.6%)
0.046
Nucleofractis Prechop
37 (17.5%)
Chop
27 (13.4%)
0.279
Nucleosclerosis Group 1 Group 2 Group 3 0.033
18 (11.6%) 37 (16.7%) 7 (31.0%)
G-P Yes
31 (14.7%)
No
33 (19.3%)
0.097

PCR = Posterior capsule rupture; G-P = Gap-period.

* Age: Group 1: 40<; Group 2: 40-69; Group 3: 70-79; Group 4: ≥80;

Axial length: Group 1: 22.5 mm<; Group 2: 22.5-23.5 mm; Group 3: ≥23.5 mm;

Nucleosclerosis: Group 1: 1, 2; Group 2: 3, 4; Group 3: 5-7 (by Lens Opacities Classification System III);

§ Pearson's chi-square test.

TOOLS
Similar articles